InventisBio

InventisBio

InventisBio

InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.
Founded
2013
Raised
$236M
Follow us
Alexa global traffic share
29 Sep 2020
12 Mar 2019
$70,000,000
Venture capital (Series C)
31 May 2017
$19,000,000
Venture capital (Series B)
Lilly Asia Ventures, OrbiMed Asia Partners

OrbiMed Asia Leads $19M Series B Round In Biotech Start-Up InventisBio

ChinaMoneyNetwork
+2